Apr 1 |
Investing in Quanterix (NASDAQ:QTRX) a year ago would have delivered you a 111% gain
|
Mar 21 |
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
|
Mar 6 |
Quanterix (QTRX) AD Offering Gets FDA's Breakthrough Device Tag
|
Mar 4 |
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
|
Mar 3 |
Quanterix Corporation (NASDAQ:QTRX) Just Released Its Annual Results And Analysts Are Updating Their Estimates
|
Mar 3 |
Quanterix Corporation (NASDAQ:QTRX) Q4 2023 Earnings Call Transcript
|
Mar 2 |
Quanterix Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags
|
Mar 1 |
Q4 2023 Quanterix Corp Earnings Call
|
Mar 1 |
Quanterix Corporation (QTRX) Q4 2023 Earnings Call Transcript
|
Feb 29 |
Quanterix GAAP EPS of -$0.33 misses by $0.02, revenue of $31.55M beats by $1.71M
|